Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Combinations of Dendritic cell-activated cytokine-induced killer cell (DC-CIK) With
chemotherapy treatment may enhance the immune response and stop cancer cells from growing.